GATM and neoplasm: In both experimental and clinical settings, tumours with high AGAT expression have demonstrated marked resistance to chlorethylating and methylating agents (Dumenco et al, 1989; Schold et al, 1989; Wu et al, 1992; Friedman et al, 1998; Jaeckle et al, 1998; Esteller et al, 2000).